UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy

Frontiers in pharmacology, 2019-05, Vol.10, p.430-430

2019

Volltextzugriff (PDF)

Antitumorigenic targets of cannabinoids - current status and implications

Expert opinion on therapeutic targets, 2016-10, Vol.20 (10), p.1219-1235

2016

Volltextzugriff (PDF)

Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases

Cells (Basel, Switzerland), 2022-12, Vol.11 (24), p.4102

2022

Volltextzugriff (PDF)

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies

Cancers, 2021-11, Vol.13 (22), p.5701

2021

Volltextzugriff (PDF)

Anti‐tumour actions of cannabinoids

British journal of pharmacology, 2019-05, Vol.176 (10), p.1384-1394

2019

Volltextzugriff (PDF)

Cannabinoids as anticancer drugs: current status of preclinical research

British journal of cancer, 2022-07, Vol.127 (1), p.1-13

2022

Volltextzugriff (PDF)

Antitumorigenic effects of cannabinoids beyond apoptosis

The Journal of pharmacology and experimental therapeutics, 2010-02, Vol.332 (2), p.336

2010

Volltextzugriff (PDF)

Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells

Pharmaceutical research, 2010-10, Vol.27 (10), p.2162-2174

2010

Volltextzugriff (PDF)

Impact of Cannabinoid Compounds on Skin Cancer

Cancers, 2022-03, Vol.14 (7), p.1769

2022

Volltextzugriff (PDF)

A Sensitive LC-MS/MS Method for the Simultaneous Determination of Two Thia-Analogous Indirubin N -Glycosides and Indirubin-3'-Monoxime in Plasma and Cell Culture Medium

Molecules (Basel, Switzerland), 2022-05, Vol.27 (9), p.3031

2022

Volltextzugriff (PDF)

Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins

Cancers, 2021-04, Vol.13 (8), p.1770

2021

Volltextzugriff (PDF)

Synergistic effect of cold gas plasma and experimental drug exposure exhibits skin cancer toxicity in vitro and in vivo

Journal of advanced research, 2024-03, Vol.57, p.181-196

2024

Volltextzugriff (PDF)

Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line

World journal of gastroenterology : WJG, 2018-09, Vol.24 (33), p.3749-3759

2018

Volltextzugriff (PDF)

Inhibition of Monoacylglycerol Lipase Decreases Angiogenic Features of Endothelial Cells via Release of Tissue Inhibitor of Metalloproteinase-1 from Lung Cancer Cells

Cells (Basel, Switzerland), 2023-06, Vol.12 (13), p.1757

2023

Volltextzugriff (PDF)

A Thia-Analogous Indirubin N-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells

Cells (Basel, Switzerland), 2023-10, Vol.12 (19), p.2409

2023

Volltextzugriff (PDF)

Cannabinoids as Anticancer Drugs

Advances in pharmacology (1990), 2017, Vol.80, p.397-436

2017

Volltextzugriff (PDF)

Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells

Molecular pharmacology, 2004-12, Vol.66 (6), p.1643-1651

2004

Volltextzugriff (PDF)

Targeting the endocannabinoid system as a potential anticancer approach

Drug metabolism reviews, 2018-01, Vol.50 (1), p.26-53

2018

Volltextzugriff (PDF)

Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases

Biochemical and biophysical research communications, 2005-12, Vol.338 (2), p.1171-1178

2005

Volltextzugriff (PDF)

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

Biochemical pharmacology, 2014-11, Vol.92 (2), p.312-325

2014

Volltextzugriff (PDF)

COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells

Molecular cancer therapeutics, 2013-01, Vol.12 (1), p.69-82

2013

Volltextzugriff (PDF)

R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells

The Journal of pharmacology and experimental therapeutics, 2006-03, Vol.316 (3), p.1219

2006

Volltextzugriff (PDF)

Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK

Biochemical pharmacology, 2014-02, Vol.87 (3), p.489-501

2014

Volltextzugriff (PDF)

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells

Biochemical pharmacology, 2014-09, Vol.91 (2), p.202-216

2014

Volltextzugriff (PDF)

Ceramide Is Involved in R(+)-Methanandamide-Induced Cyclooxygenase-2 Expression in Human Neuroglioma Cells

Molecular pharmacology, 2003-11, Vol.64 (5), p.1189-1198

2003

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

ThemaBiochemistry & Molecular Biology

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(91)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(105)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy

Antitumorigenic targets of cannabinoids - current status and implications

Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies

Anti‐tumour actions of cannabinoids

Cannabinoids as anticancer drugs: current status of preclinical research

Antitumorigenic effects of cannabinoids beyond apoptosis

Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells

Impact of Cannabinoid Compounds on Skin Cancer

A Sensitive LC-MS/MS Method for the Simultaneous Determination of Two Thia-Analogous Indirubin N -Glycosides and Indirubin-3'-Monoxime in Plasma and Cell Culture Medium

Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins

Synergistic effect of cold gas plasma and experimental drug exposure exhibits skin cancer toxicity in vitro and in vivo

Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line

Inhibition of Monoacylglycerol Lipase Decreases Angiogenic Features of Endothelial Cells via Release of Tissue Inhibitor of Metalloproteinase-1 from Lung Cancer Cells

A Thia-Analogous Indirubin N-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells

Cannabinoids as Anticancer Drugs

Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells

Targeting the endocannabinoid system as a potential anticancer approach

Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells

R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells

Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells

Ceramide Is Involved in R(+)-Methanandamide-Induced Cyclooxygenase-2 Expression in Human Neuroglioma Cells

Aktive Filter

Suchergebnisse filtern